Deliver Your News to the World

News

Distribute Your News

  • Every day, hundreds of individuals and companies choose WebWire to distribute their news.
  • WebWire places your news within numerous highly trafficked news search engines generating leads and publicity.
  • Submit Your Release Now!

Health Care / Hospitals

Releases published in the last 30 days. RSS 0.91 Feed

Page 3 of 3

Common Respiratory Irritants in Puerto Rico’s Homes, Schools, and Businesses
Common Respiratory Irritants in Puerto Rico’s Homes, Schools, and Businesses
1/5/2026 2:44:18 PM
The U.S. Environmental Protection Agency (EPA) warns that indoor air can be up to five times more polluted than outdoor air, a concern that extends beyond residences to workplaces, schools, and other commercial or institutional spaces across Puerto Rico.
Robert Cohen of Stryker Named Chair of AdvaMed’s Digital Health Tech Division Board of Directors
Robert Cohen of Stryker Named Chair of AdvaMed’s Digital Health Tech Division Board of Directors
1/5/2026 12:01:33 PM
AdvaMed, the Medtech Association, today announced that Robert Cohen, vice president, innovation and technology, orthopaedic group at Stryker, will be the next chair of the AdvaMed Digital Health Tech Board of Directors.
Blockchain in Healthcare Today Releases New Issue Advancing Decentralized Health, AI, and Trust-Driven Innovation
Blockchain in Healthcare Today Releases New Issue Advancing Decentralized Health, AI, and Trust-Driven Innovation
1/5/2026 8:30:00 AM
Blockchain in Healthcare Today (BHTY), a peer reviewed platform journal at the intersection of blockchain, artificial intelligence, and decentralized health systems, opens the new year with a powerful new issue focused on evidence, governance, and real world implementation of next generation healthcare technologies.
Johnson & Johnson completes acquisition of Halda Therapeutics and its novel platform to revolutionize cancer treatment and enable next-generation oral therapies
Johnson & Johnson completes acquisition of Halda Therapeutics and its novel platform to revolutionize cancer treatment and enable next-generation oral therapies
12/30/2025 1:23:34 PM
Johnson & Johnson (NYSE: JNJ) (the “Company”) announced the successful completion of its acquisition of Halda Therapeutics OpCo, Inc. (“Halda”), a clinical-stage biotechnology company with a proprietary Regulated Induced Proximity TArgeting Chimera (RIPTAC™) platform to develop oral, targeted therapies for multiple types of solid tumors, including prostate cancer, for $3.05 …